Eli Lilly and Company’s Olumiant (baricitinib) has been recommended for approval in Europe for adolescents with severe ...

Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...

Atrium Therapeutics Inc. has launched as a newly independent, publicly traded company dedicated to delivering RNA therapeutics.

WuXi XDC Cayman Inc. has entered a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform.

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

Asahi Kasei Pharma has entered an exclusive global license agreement with Alchemedicine covering novel lead compounds for a ...

Nexus Precision Health, a precision medicine technology company, has acquired Leal Health, an AI-powered patient ...

Boehringer Ingelheim has acquired an exclusive license for a preclinical, small molecule program from Sitryx Therapeutics.

Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO ...

Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...

Asahi Kasei has agreed to acquire all issued shares of Aicuris Anti-infective Cures AG, a German-based biopharmaceutical company.

Validogen is launching next-generation synthetic methanol-free promoters, which may lead to “substantially increased productivities.” ...